ArticleDiscover oncology2026
Comparative analysis of trends and projections of cervical cancer burden among women aged 20-64 years in China, Japan, and South Korea, 1990-2050.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer remains a major public health challenge in East Asia, with heterogeneous epidemiological patterns across countries. A comprehensive comparison of long-term trends and future trajectories is essential to inform region-specific prevention strategies.
methodsUsing data from the Global Burden of Disease 2021 study, we analyzed incidence, prevalence, disability-adjusted life years (DALYs), and mortality of cervical cancer among women aged 20-64 years in China, Japan, and South Korea from 1990 to 2021. Temporal trends were assessed using Joinpoint regression, and future burdens were projected through 2050 using established demographic and epidemiological modeling frameworks.
resultsMarked cross-country differences were observed. China exhibited sustained increases in incidence and prevalence over the past three decades, while mortality and DALYs declined only modestly. For example, the age-standardized incidence rate in China increased from 16.74 per 100,000 population in 1990 (95% CI: 13.04-21.14) to 19.76 per 100,000 population in 2021 (95% CI: 13.99-26.14). In contrast, Japan showed relatively stable incidence and mortality rates, accompanied by moderate increases in prevalence, reflecting prolonged survival. South Korea demonstrated consistent declines across incidence, mortality, and DALYs, representing the most pronounced improvement among the three countries. Future projections suggest that, without intensified prevention efforts, the cervical cancer burden in China will continue to rise, whereas Japan and South Korea are expected to maintain stable or declining trends.
conclusionsThe burden of cervical cancer in East Asia shows substantial divergence. China faces a growing challenge, while Japan and South Korea have achieved more effective disease control. These findings underscore the need for tailored prevention and control strategies adapted to national contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.